Growth Hormone · Peptide Guide
CJC-1295 & Ipamorelin tracker
Also known as: GHRH + GHRP stack
Track the CJC-1295 + Ipamorelin growth hormone stack in AI Peps.
What is CJC-1295 & Ipamorelin?
The CJC-1295 (no DAC) + Ipamorelin stack is one of the most common growth-hormone-releasing protocols. Injections are typically taken 1–3 times daily on an empty stomach. AI Peps tracks each injection, timing windows, and cycle length across both peptides in one view.
Common doses
CJC-1295: 100 mcg · Ipamorelin: 100–300 mcg per dose
Frequency
1–3x daily (morning, pre-workout, before bed)
Cycle length
8–12 weeks on, 4 weeks off
Administration
Subcutaneous injection on empty stomach
Storage
Refrigerate reconstituted vials at 2–8°C
Why track CJC-1295 & Ipamorelin in AI Peps
- ✦Pulsatile GH release
- ✦Improved sleep quality
- ✦Recovery and body composition support
- ✦Minimal cortisol or prolactin impact (Ipamorelin)
Considerations
- ·Research chemical — not FDA approved for human use
- ·Best on an empty stomach for absorption
- ·Cycle off periodically
AI Peps is a tracking tool, not medical advice. Always consult a qualified clinician before starting any peptide or GLP-1 protocol.
CJC-1295 & Ipamorelin — frequently asked questions
Can AI Peps track two peptides in one stack?
Yes. AI Peps runs multiple concurrent protocols and shows a unified schedule so CJC-1295 and Ipamorelin injections appear together in your daily log.
Track CJC-1295 & Ipamorelin the smart way
Download AI Peps free on the App Store — dose logging, cycle tracking, and AI insights for CJC-1295 & Ipamorelin.
Related peptide guides
Healing
BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It is widely researched for its role in tissue repair, tendon and ligament healing, and gut integrity.
Healing
TB-500
TB-500 is a synthetic fragment of Thymosin Beta-4 studied for systemic healing, cell migration, and recovery from soft-tissue injury.
GLP-1
Semaglutide
Semaglutide is a GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy).